Journal of Chemical Technology & Biotechnology
Research Article

Long‐term expansion of human induced pluripotent stem cells in a microcarrier‐based dynamic system

Sara M Badenes

Department of Bioengineering, and Institute for Bioengineering and Biosciences, Instituto Superior Técnico, Universidade de Lisboa, Portugal

Search for more papers by this author
Tiago G Fernandes

Department of Bioengineering, and Institute for Bioengineering and Biosciences, Instituto Superior Técnico, Universidade de Lisboa, Portugal

Search for more papers by this author
Cláudia C Miranda

Department of Bioengineering, and Institute for Bioengineering and Biosciences, Instituto Superior Técnico, Universidade de Lisboa, Portugal

Search for more papers by this author
Annette Pusch‐Klein

Institute of Reconstructive Neurobiology, LIFE & BRAIN Center, University of Bonn, Germany

Search for more papers by this author
Simone Haupt

Institute of Reconstructive Neurobiology, LIFE & BRAIN Center, University of Bonn, Germany

Search for more papers by this author
Carlos AV Rodrigues

Department of Bioengineering, and Institute for Bioengineering and Biosciences, Instituto Superior Técnico, Universidade de Lisboa, Portugal

Search for more papers by this author
Maria Margarida Diogo

Department of Bioengineering, and Institute for Bioengineering and Biosciences, Instituto Superior Técnico, Universidade de Lisboa, Portugal

Search for more papers by this author
Oliver Brüstle

Corresponding Author

E-mail address: oliver.bruestle@uni-bonn.de

Institute of Reconstructive Neurobiology, LIFE & BRAIN Center, University of Bonn, Germany

German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany

Correspondence to: JMS Cabral, Department of Bioengineering, and Institute for Bioengineering and Biosciences, Instituto Superior Técnico, Av. Rovisco Pais, 1049–001 Lisboa, Portugal. Email:

joaquim.cabral@tecnico.ulisboa.pt

; or O Brüstle, Institute of Reconstructive Neurobiology, Sigmund‐Freud‐Straße 25, D‐53127 Bonn, Germany. Email:

oliver.bruestle@uni-bonn.de

Search for more papers by this author
Joaquim MS Cabral

Corresponding Author

E-mail address: joaquim.cabral@tecnico.ulisboa.pt

Department of Bioengineering, and Institute for Bioengineering and Biosciences, Instituto Superior Técnico, Universidade de Lisboa, Portugal

Correspondence to: JMS Cabral, Department of Bioengineering, and Institute for Bioengineering and Biosciences, Instituto Superior Técnico, Av. Rovisco Pais, 1049–001 Lisboa, Portugal. Email:

joaquim.cabral@tecnico.ulisboa.pt

; or O Brüstle, Institute of Reconstructive Neurobiology, Sigmund‐Freud‐Straße 25, D‐53127 Bonn, Germany. Email:

oliver.bruestle@uni-bonn.de

Search for more papers by this author
First published: 25 August 2016
Cited by: 9
Get access to the full version of this article.View access options below.

Log in with Open Athens, Shibboleth, or your institutional credentials.

If you have previously obtained access with your personal account, .

Abstract

BACKGROUND

Human induced pluripotent stem (hiPS) cells provide a fascinating tool for exploring disease mechanisms, compound screening in pharmaceutical drug development, and might also represent a renewable source of cells for regenerative medicine applications. This requires increased cell quantities, generated under Good Manufacturing Practice‐compatible conditions in a scalable system.

RESULTS

A microcarrier‐based suspension culture was explored for scaling‐up hiPS cell expansion in serum‐free medium using synthetic peptide‐acrylate surface microcarriers, developed for long‐term support of hiPS cell self‐renewal. After a 7 day‐culture in a spinner flask, cells maintained their typical morphology, pluripotency‐associated marker expression and their differentiation capability. Envisaging improvement of the scalability of the culture, long‐term expansion on the microcarriers was attained using confluent microcarriers as the inoculum of successive spinner flask cultures. Importantly, bead‐to‐bead cell transfer allowed four consecutive sub‐culture procedures and a cumulative 241‐fold expansion was achieved within 15 days, leading to a total viable cell number of 3.3 × 108 cells.

CONCLUSION

This work is expected to enable the scale‐up of hiPS cell culture under defined conditions and potentially leading to the use of pluripotent stem cell derivatives in cell replacement therapies. © 2016 Society of Chemical Industry

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.